Anti-EOGT antibodies are used in the immunodetection of the protein EGF domain specific O-linked N-acetylglucosamine transferase. In humans, the canonical protein has a reported length of 527 amino acid residues and a mass of 62 kDa. Its subcellular localization is in the ER. Up to 3 different isoforms have been reported for this protein. It is notably widely expressed in many tissue types. A member of the Glycosyltransferase 61 protein family, EOGT is known to catalyze the transfer of a single N-acetylglucosamine from UDP-GlcNAc to a serine or threonine residue in extracellular proteins resulting in their modification with a beta-linked N-acetylglucosamine (O-GlcNAc). Synonyms for this target antigen include EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase, EGF-O-GlcNAc transferase, extracellular O-linked N-acetylglucosamine transferase, and AER61 glycosyltransferase. Some EOGT antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. In addition, Immunofluorescence is also a common application.